Renal-protective effect of temocapril, a biliary excretive ACE inhibitor, in diabetic nephropathy.

被引：0
|
作者：
Kato, K [1 ]
Midorikawa, S [1 ]
Shigetomi, S [1 ]
Mizuno, K [1 ]
机构：
[1] FUKUSHIMA MED COLL,DEPT INTERNAL MED 3,FUKUSHIMA,JAPAN
来源：
DIABETOLOGIA | 1997年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1433 / 1433
页数：1
相关论文
共 50 条
  • [41] Protective effect of enalapril on vascular damage in patients with IgA nephropathy.
    Praga, M
    Hernandez, E
    Toledo, T
    Alamo, A
    Mon, C
    Rodicio, JL
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A0475 - A0475
  • [42] Lack of relation between renal kallikrein gene polymorphism and diabetic nephropathy.
    Torremocha, F
    Marechaud, R
    Marre, M
    Passa, P
    Rodier, M
    AlhencGelas, F
    Jeunemaitre, X
    DIABETOLOGIA, 1997, 40 : 2043 - 2043
  • [43] Gender differences in renal expression of ACE and ACE2 in diabetic nephropathy
    Bader, M
    Iliescu, R
    Campos, LA
    Baltatu, O
    HYPERTENSION, 2003, 42 (04) : 645 - 645
  • [44] The protective effect of the RAS inhibitor on diabetic patients with nephropathy in the context of VEGF suppression
    Hai-bing Chen
    Jun-xi Lu
    Qing Li
    Yu-qian Bao
    Jun-ling Tang
    Hui-juan Lu
    Kun-san Xiang
    Wei-ping Jia
    Acta Pharmacologica Sinica, 2009, 30 : 242 - 250
  • [45] The protective effect of the RAS inhibitor on diabetic patients with nephropathy in the context of VEGF suppression
    Chen, Hai-bing
    Lu, Jun-xi
    Li, Qing
    Bao, Yu-qian
    Tang, Jun-ling
    Lu, Hui-juan
    Xiang, Kun-san
    Jia, Wei-ping
    ACTA PHARMACOLOGICA SINICA, 2009, 30 (02) : 242 - 250
  • [46] Comparison of long-term therapeutic effect of an ACE inhibitor, temocapril, with that of a diuretic on microalbuminuria in non-diabetic essential hypertension
    Shionoiri, H
    Kosaka, T
    Kita, E
    Takizawa, T
    Takasaki, I
    HYPERTENSION RESEARCH, 2000, 23 (06) : 593 - 600
  • [47] Renal-protective effect of thalidomide in streptozotocin-induced diabetic rats through anti-inflammatory pathway
    Zhang, Hogxia
    Yang, Yanlan
    Wang, Yanqin
    Wang, Baodong
    Li, Rongshan
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2018, 12 : 89 - 98
  • [48] Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy
    Abdel-Wahab, Ali F.
    Bamagous, Ghazi A.
    Al-Harizy, Randa M.
    ElSawy, Naser A.
    Shahzad, Naiyer
    Ibrahim, Ibrahim A.
    Al Ghamdi, Saeed S.
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 103 : 59 - 66
  • [49] SINGLE-DOSE PHARMACOKINETICS OF TEMOCAPRIL, AN ACE-INHIBITOR WITH PREFERENTIAL BILIARY-EXCRETION, IN DIALYSIS PATIENTS
    TOKOO, M
    OGUCHI, H
    SATO, K
    TERASHIMA, M
    MIYASAKA, M
    KASAHARA, H
    SAITO, H
    KAWAHARA, Y
    SHIOYA, H
    FURUTA, S
    DRUG INVESTIGATION, 1994, 7 (05): : 254 - 261
  • [50] Combining ACE inhibitors and angiotensin II receptor blockers to decrease proteinuria in patients with diabetic nephropathy.
    Dhillon, KK
    Mason, E
    Nanovic, L
    Laplace, L
    McCune, TR
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 602A - 602A
12345